Veerhealth Care Limited

As of June 30, 2026, Veerhealth Care Limited carries a market capitalization of 649.75M, placing it among publicly traded companies globally. Its enterprise value stands at 649.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Veerhealth Care Limited has 20.00M shares outstanding.

As of June 30, 2026, Veerhealth Care Limited trades at a trailing price-to-earnings ratio of 42.15.

As of June 30, 2026, Veerhealth Care Limited trades at an EV/EBITDA multiple of 15.87 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.23 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.87 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 649.75M versus a market cap of 649.75M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 10.18M in revenue per employee across its workforce of 52.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Veerhealth Care Limited recorded 9.64M in income tax expense. That works out to an effective tax rate of 38.65, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 24.94M, leaving 15.30M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Veerhealth Care Limited's stock has gained approximately 168.94% over the past 52 weeks. The 50-day moving average sits at 49.44, while the 200-day moving average is 31.15.

Over the twelve months ended June 30, 2026, Veerhealth Care Limited generated 529.25M in revenue and converted that into 15.30M in net income, yielding earnings per share of 0.76. EBITDA reached 40.94M, while operating income came in at 30.32M.

Over the twelve months ended June 30, 2026, Veerhealth Care Limited posted a gross margin of 22.58, reflecting its pricing power and cost economics. The operating margin of 5.73 and net profit margin of 2.89 provide insight into operational efficiency.

Veerhealth Care Limited's most recent stock split took place on September 22, 2023 with a 1:2 split ratio.